tamoxifen

Sweden, February 24: Patients suffering from hard-to-beat cancers have a glimmer of hope coming their way from the researchers at Lund University, Malmo, Sweden. The anti-cancerdefine drug

The researchers, led by Caroline Ford, have looked into a method to re-establish the susceptibility of breast cancerdefine cells to Tamoxifendefine.

Tamoxifen therapy is commonly employed to inhibit cell proliferation and induce cell death in the patient by binding the drug to the oestrogen receptors of the cancer cells. But oestrogen receptors are not present on the cell surface in one-third of the breast cancer cases, thus rendering Tamoxifen ineffective.